Proglucagon-Derived Peptides Do Not Significantly Affect Acute Exocrine Pancreas in Rats

about

Proglucagon-Derived Peptides Do Not Significantly Affect Acute Exocrine Pancreas in Rats

Item

http://www.wikidata.org/entity/Q36763274

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

Proglucagon-Derived Peptides Do Not Significantly Affect Acute Exocrine Pancreas in Rats

@ast

Proglucagon-Derived Peptides Do Not Significantly Affect Acute Exocrine Pancreas in Rats

@en

type

Item

label

Proglucagon-Derived Peptides Do Not Significantly Affect Acute Exocrine Pancreas in Rats

@ast

Proglucagon-Derived Peptides Do Not Significantly Affect Acute Exocrine Pancreas in Rats

@en

prefLabel

Proglucagon-Derived Peptides Do Not Significantly Affect Acute Exocrine Pancreas in Rats

@ast

Proglucagon-Derived Peptides Do Not Significantly Affect Acute Exocrine Pancreas in Rats

@en

P1476

Proglucagon-Derived Peptides Do Not Significantly Affect Acute Exocrine Pancreas in Rats

@en

P2093

Antonia M Solomou

http://www.w3.org/2001/XMLSchema#string

Elina Akalestou

http://www.w3.org/2001/XMLSchema#string

James S Minnion

http://www.w3.org/2001/XMLSchema#string

Stephen R Bloom

http://www.w3.org/2001/XMLSchema#string

P2860

Marked expansion of exocrine and endocrine pancreas with incretin therapy in humans with increased exocrine pancreas dysplasia and the potential for glucagon-producing neuroendocrine tumors

Increased risk of acute pancreatitis and biliary disease observed in patients with type 2 diabetes: a retrospective cohort study

Chronic GLP-1 receptor activation by exendin-4 induces expansion of pancreatic duct glands in rats and accelerates formation of dysplastic lesions and chronic pancreatitis in the Kras(G12D) mouse model.

PYY3-36 and oxyntomodulin can be additive in their effect on food intake in overweight and obese humans.

Glucagonlike peptide 1-based therapies and risk of hospitalization for acute pancreatitis in type 2 diabetes mellitus: a population-based matched case-control study.

Divergent effects of liraglutide, exendin-4, and sitagliptin on beta-cell mass and indicators of pancreatitis in a mouse model of hyperglycaemia

Vagal afferent pathway mediates physiological action of cholecystokinin on pancreatic enzyme secretion

Acute pancreatitis in association with type 2 diabetes and antidiabetic drugs: a population-based cohort study

A meta-analysis of serious adverse events reported with exenatide and liraglutide: acute pancreatitis and cancer.

Oxyntomodulin increases energy expenditure in addition to decreasing energy intake in overweight and obese humans: a randomised controlled trial.

P304

967-973

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1097/MPA.0000000000000585

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Guy A. Rutter

Ioannis Christakis

P577

2016-01-05T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

26731187

http://www.w3.org/2001/XMLSchema#string

P921

Aizkuņģa dziedzeris

P932

4820085

http://www.w3.org/2001/XMLSchema#string